[Upper digestive bleedings after cardiac surgery].

Ann Cardiol Angeiol (Paris)

Service de chirurgie cardiovasculaire Hay-Riad, hôpital militaire d'instruction Mohammed-V, 10100 Rabat, Maroc.

Published: June 2007

Introduction: Upper gastrointestinal haemorrhage (UGH) following cardiac surgery is infrequent with high mortality. The aim of this study is to compare the frequency and outcome of UGH in patients who had undergone open heart surgery at our institution.

Patients And Methods: From January 1994 to December 2005, 1278 cardiac operations were performed. A systematic prophylaxis antiacid was used by antagonists of histaminic receptor (anti-H2, ranitidine 150 mg/12 h) in all patients. The diagnosis was based on clinical symptoms (haematemesis and/or melaena) in the postoperative period and confirmed by fibroscopy. We conducted a retrospective study of these patients.

Results: Only 8 of the 1278 (0,6%) cardiac operations were complicated by UGH. Demographic data were reported in Table 1. The mean interval between surgery and UGH was 10+/-3,7 days (range 5,15 days). Gastro-duodenal ulcer was the most common cause of UGH in 5 patients (62%), ulcero-hemorrhagic eosophagitis was developed in one patient (12,5%), candidosic eosophagitis in one and multiple gastric ulcer in one patient (12,5%). Medical treatment was applied in 6 patients (72%) with successful result. Surgical intervention was necessary in 2 patients (25%). 2 patients had repeat gastrointestinal bleeding. One patient was died; he was recorded as having severe sepsis and multiple organ failure in addition to UGH.

Conclusion: UGH in patients undergoing heart operation is rare but associated with poor prognosis despite antiacid prophylaxis. These complications occurred in patients who had in postoperative bad hemodynamic conditions.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ancard.2007.02.002DOI Listing

Publication Analysis

Top Keywords

ugh patients
12
patients
8
cardiac operations
8
patient 125%
8
ugh
6
[upper digestive
4
digestive bleedings
4
cardiac
4
bleedings cardiac
4
cardiac surgery]
4

Similar Publications

Uveitis glaucoma hyphema syndrome as a result of glaucoma implant: A case report.

World J Clin Cases

October 2024

Glaucoma and Cataract, Department of Ophthalmology, King Abdulaziz University Hospital, King Saud University, Riyadh 15112, Saudi Arabia.

Article Synopsis
  • * A case was reported involving a 55-year-old woman who developed hyphema and pigmentation after AGV implantation, leading to the rare UGH syndrome, which was not previously documented as a complication of this surgery.
  • * Following a second surgery to adjust the AGV tube, the patient's IOP improved, and she showed no further signs of complications, highlighting the importance of regular follow-up for patients after AGV implantation.
View Article and Find Full Text PDF

A case of delayed recurrent hyphema following Implantable Collamer Lens (ICL) surgery.

Am J Ophthalmol Case Rep

December 2024

The First Affiliated Hospital of Chongqing Medical University, Chongqing Key Laboratory of Prevention and Treatment on Major Blinding Diseases, Chongqing Eye Institute, Chongqing Branch (Municipality Division) of National Clinical Research Center for Ocular Diseases, Chongqing, 400016, PR China.

Purpose: To present a case of delayed recurrent hyphema following toric ICL implantation.

Observations: This case reports a 24-year-old Asian female who presented with sudden decrease in vision in the right eye, accompanied by recurrent massive anterior chamber hemorrhage, six months after bilateral implantation of toric ICL with central holes for myopia correction. Despite initial conservative treatment with immobilization and intraocular pressure (IOP)-lowering medication at another hospital, the hyphema persisted.

View Article and Find Full Text PDF

Purpose: The Hydrus microstent was approved by the FDA in August 2018 for use with cataract surgery to reduce IOP in patients with mild to moderate primary open angle glaucoma (POAG). Pivotal clinical trials demonstrated its overall safety and efficacy in lowering IOP. However, malpositioning of the implant can result in uveitis-glaucoma-hyphema (UGH) syndrome necessitating device explantation.

View Article and Find Full Text PDF

Introduction: Uveitis-glaucoma-hyphema (UGH) syndrome is an infrequent but severe complication following intraocular lens implantation, characterized by anterior chamber inflammation and elevated intraocular pressure (IOP). This report presents a rare case of late-onset UGH syndrome induced by a well-positioned 1-piece posterior capsular intraocular lens (PCIOL) with a bulb of the haptics extruding through a peripheral capsular tear in a 90-year-old female, 17 years post-cataract surgery.

Case Presentation: The patient presented with persistent blurred vision, recurrent anterior uveitis, and uncontrolled IOP despite medical therapy.

View Article and Find Full Text PDF

Anterior Segment Optical Coherence Tomography in Uveitis-Glaucoma-Hyphema Syndrome.

Ocul Immunol Inflamm

November 2024

Ocular Immunology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Purpose: Uveitis-Glaucoma-Hyphema (UGH) syndrome results from contact between the intraocular lens (IOL) and the iris or ciliary body, leading to uveal structure erosion and blood-aqueous barrier breakdown. Treatment involves various drugs, with IOL removal often being necessary. Diagnosis relies on clinical signs, but imaging techniques like ultrasound biomicroscopy (UBM) or anterior segment optical coherence tomography (AS-OCT) are crucial.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!